This report focuses on the global Irritable Bowel Syndrome (IBS) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Irritable Bowel Syndrome (IBS) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study Allergan Bausch Health Takeda Sucampo Pharmaceuticals McNeil Consumer Healthcare Sebela Pharmaceuticals Astellas Pharmaceuticals IM HealthScience Market segment by Type, the product can be split into IBS-D Drug IBS-C Drug Other Market segment by Application, split into Women Men Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Irritable Bowel Syndrome (IBS) status, future forecast, growth opportunity, key market and key players. To present the Irritable Bowel Syndrome (IBS) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by type, market and key regions. In this study, the years considered to estimate the market size of Irritable Bowel Syndrome (IBS) are as follows: History Year: 2015-2019 Base Year: 2019 Estimated Year: 2020 Forecast Year 2020 to 2026 For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Irritable Bowel Syndrome (IBS) Revenue 1.4 Market Analysis by Type 1.4.1 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 IBS-D Drug 1.4.3 IBS-C Drug 1.4.4 Other 1.5 Market by Application
